<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02665520</url>
  </required_header>
  <id_info>
    <org_study_id>Elaj stem cells 1</org_study_id>
    <nct_id>NCT02665520</nct_id>
  </id_info>
  <brief_title>Penile Intracavernosal Stem Cells Therapy for Erectile Dysfunction</brief_title>
  <official_title>Phase 1 Study of the Use of Autologous Penile Stem Cells in Men With Erectile Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Elaj medical centers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King Saud University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Elaj medical centers</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Autologous Fat Derived Stem Cell treatment of ED.

      To assess safety and primary efficacy of stem cell infusion in refractory ED.

      To investigate the success rate and durability of success of using this new therapy in
      management of moderate and sever cases of erectile dysfunction.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse Events that occur during or after the procedure to measure safety and tolerability</measure>
    <time_frame>1 year</time_frame>
    <description>to assess efficacy and safety of injection of stem autologous stem cells in penis of ED patients</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>stem cells injection in penis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment Injection of adipose derived cells into penis experimental;randomised</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controled arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>liposuction for retrieval of own stem cells from fat cells</intervention_name>
    <arm_group_label>stem cells injection in penis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male 40 years old and older suffering from moderate to sever erectile dysfunction -

        Exclusion Criteria:

          -  Inability to give informed consent or attend follow up

          -  Severe diabetic neuropathy (to be defined ? Charcot joints, diabetic ulcers?) or other
             neuropathic disease

          -  Viral disease from infectivity viewpoint

          -  Major penile fibrosis or severe Peyronie's disease

          -  Severe primary large vessel ED (defined as PSV less than 15cm/s after ICI)

          -  Severe primary venous leakage ED (defined as EDV more than 10cm/s after ICI)

          -  Prior systemic chemotherapy, or radiotherapy to donor or recipient area

          -  Not in potentially active sexual relationship

          -  Age less than 40 or over 70
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saleh Binsaleh, MD</last_name>
    <role>Study Director</role>
    <affiliation>King Saud University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>MOHAMAD HABOUS, M.D;FEBU</last_name>
    <phone>+966599950131</phone>
    <email>drmhabos@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saleh Binsaleh, MD</last_name>
    <phone>+966502100034</phone>
    <email>surgon@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Elaj medical group</name>
      <address>
        <city>Jedda</city>
        <state>Outside U.S./Canada</state>
        <zip>21463</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamad Habous</last_name>
      <phone>+966599950131</phone>
      <email>drmhabos@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Saleh Binsaleh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>kING SAUD UNIVERSITY</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saleh Binsaleh, MD</last_name>
      <phone>+966502100034</phone>
      <email>surgon@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2015</study_first_submitted>
  <study_first_submitted_qc>January 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2016</study_first_posted>
  <last_update_submitted>January 26, 2016</last_update_submitted>
  <last_update_submitted_qc>January 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Elaj medical centers</investigator_affiliation>
    <investigator_full_name>Mohamad Habous</investigator_full_name>
    <investigator_title>Dr Mohamad Habous</investigator_title>
  </responsible_party>
  <keyword>stem cells injections</keyword>
  <keyword>erectile dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

